Average Co-Inventor Count = 5.98
ph-index = 29
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immatics Biotechnologies Gmbh (502 from 725 patents)
2. Other (1 from 831,952 patents)
505 patents:
1. 12351616 - Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
2. 12297254 - Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
3. 12297245 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
4. 12295994 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
5. 12295995 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
6. 12295996 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
7. 12281146 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
8. 12275768 - In immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
9. 12275775 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
10. 12275776 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
11. 12258382 - Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
12. 12247057 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
13. 12240877 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
14. 12240878 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
15. 12234298 - Immunotherapy against several tumors including neuronal and brain tumors